rs387906874
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_004281.4(BAG3):c.211C>T(p.Arg71Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000075 in 1,614,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R71L) has been classified as Likely benign.
Frequency
Consequence
NM_004281.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BAG3 | NM_004281.4 | c.211C>T | p.Arg71Trp | missense_variant | 2/4 | ENST00000369085.8 | NP_004272.2 | |
BAG3 | XM_005270287.2 | c.211C>T | p.Arg71Trp | missense_variant | 2/4 | XP_005270344.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BAG3 | ENST00000369085.8 | c.211C>T | p.Arg71Trp | missense_variant | 2/4 | 1 | NM_004281.4 | ENSP00000358081.4 | ||
BAG3 | ENST00000450186.1 | c.37C>T | p.Arg13Trp | missense_variant | 3/5 | 5 | ENSP00000410036.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251304Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135842
GnomAD4 exome AF: 0.0000759 AC: 111AN: 1461866Hom.: 0 Cov.: 32 AF XY: 0.0000839 AC XY: 61AN XY: 727240
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74368
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego | May 14, 2019 | - - |
Uncertain significance, criteria provided, single submitter | research | Lildballe Lab, Aarhus University Hospital | Mar 01, 2024 | PM2(s), BP6(sup) - |
Uncertain significance, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
Myofibrillar myopathy 6;C3151293:Dilated cardiomyopathy 1HH Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
Dilated cardiomyopathy 1HH Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 11, 2011 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 25, 2020 | The BAG3 c.211C>T; p.Arg71Trp variant (rs387906874) is reported in the literature in several individuals affected with cardiomyopathy (Norton 2011, Cowan 2018, van Lint 2019). This variant is also reported in ClinVar (Variation ID: 30396). This variant is found in the Finnish European population with an allele frequency of 0.07% (17/25104 alleles) in the Genome Aggregation Database. The arginine at codon 71 is moderately conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.37). Due to limited information, the clinical significance of the p.Arg71Trp variant is uncertain at this time. Pathogenic variants in BAG3 are associated with autosomal dominant dilated cardiomyopathy 1HH (MIM: 613881) and myofibrillar myopathy 6 (MIM: 612954). References: Norton et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet. 2011 Mar 11;88(3):273-82. Cowan et al. Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Nonsegregating LMNA Pedigrees. Circ Genom Precis Med. 2018 Jul;11(7):e002038. van Lint et al. Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance. Neth Heart J. 2019 Jun;27(6):304-309. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 16, 2023 | Variant summary: BAG3 c.211C>T (p.Arg71Trp) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00014 in 251304 control chromosomes (gnomAD). The observed variant frequency is approximately 4-fold of the estimated maximal expected allele frequency for a pathogenic variant in BAG3 causing Dilated Cardiomyopathy phenotype (3.9e-05), strongly suggesting that the variant is benign. c.211C>T has been reported in the literature in two individuals affected with Dilated Cardiomyopathy from the same family, however both also shared variants in other cardiac-related genes (Norton_2011, Cowan_2018). This report does not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. The variant has also been reported in an individual with an unknown/unspecified cardiomyopathy who had a co-occurring pathogenic variant in MYBPC3 (c.1505G>A, p.Arg502Gln), providing supporting evidence for a benign role (van Lint_2019). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30012837, 21353195, 30847666). Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as either VUS (n=3) or likely benign (n=2). Based on the evidence outlined above, the variant was classified as likely benign. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at